Checkmate Pharmaceuticals

Checkmate Pharmaceuticals

Checkmate Pharmaceuticals

Checkmate Pharmaceuticals, a Cambridge, MA-based clinical stage biotechnology company with a novel approach to cancer immunotherapy.
Founded
2015
Raised
$134M
Follow us
Alexa global traffic share
10 Jun 2020
$85,000,000
Venture capital (Series C)

Checkmate Pharmaceuticals Raises $85M in Series C Financing

FinSMEs
+1
12 Dec 2018
$22,000,000
Venture capital (Series C)

Checkmate Pharmaceuticals Closes $22M Financing

FinSMEs
15 Jun 2017
$27,000,000
Venture capital (Series B)

Checkmate Pharmaceuticals Secures $27 Million Series B Preferred Financing and Appoints Karen Brennan as Chief Operating Officer

businesswire
+2